Stocks Health care CHE
NYSE · Health careChemed Corp (CHE)
Chemed Corp brought in $2.7B of revenue over the twelve months to September 30, 2026, up 5.2% from a year earlier. Net income was $282.4M, a net margin of 10.6%. Operating cash flow minus capital spending left $325.5M of free cash flow in fiscal 2025. At September 30, 2026 it held $48.4M in cash against $236M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Chemed Corp
- Net worth
- Chemed Corp has a market value (market cap) of $7.1B at the latest share price, and shareholders' equity of $861.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.5B (+4.1% year on year), with net income of $265.2M. Over the 12 months to September 30, 2026: revenue $2.7B, net income $282.4M.
- Cash flow
- In fiscal 2025 operations brought in $388.3M of cash; after $62.8M of capital spending, free cash flow was $325.5M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Chemed Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Chemed Corp paid dividends of $2.20 per share in fiscal 2025, a yield of 0.41% at the current price.
What Chemed Corp does
Chemed Corp is registered with the SEC under industry code SIC 8082 (Services-Home Health Care Services). Its shares trade on NYSE under the ticker CHE.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.5B | $265.2M | $18.34 | $325.5M |
| 2024 | $2.4B | $302M | $19.89 | $368M |
| 2023 | $2.3B | $272.5M | $17.93 | $273.4M |
| 2022 | $2.1B | $249.6M | $16.53 | $252.6M |
| 2021 | $2.1B | $268.6M | $16.85 | $249.9M |
| 2020 | $2.1B | $319.5M | $19.48 | $430.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CHE ranks in Health care
Dividends
Chemed Corp paid $2.20 per share in fiscal 2025. At the current price that is a yield of 0.41%. It paid out $31.7M in cash dividends, 12% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $2.20 | $31.7M | 12% |
| 2024 | $1.80 | $27.1M | 9% |
| 2023 | $1.56 | $23.5M | 9% |
| 2022 | $1.48 | $22M | 9% |
| 2021 | $1.40 | $22M | 8% |
| 2020 | $1.32 | $21.1M | 7% |
Latest SEC filings
What Chemed Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 11% to $690.9M versus the same quarter last year; diluted EPS $5.45 versus $4.46.
- October 27, 2026
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- July 31, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 8.8% to $673.3M versus the same quarter last year; diluted EPS $5.13 versus $3.57.
- July 28, 2026
- June 24, 2026
- May 19, 2026
- April 29, 2026Passive stake (5% or more) SCHEDULE 13G
- April 29, 2026Passive stake (5% or more) SCHEDULE 13G
- April 28, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 1.6% to $657.5M versus the same quarter last year; diluted EPS $4.84 versus $4.86.
What is CHE worth? A DCF from its reported cash flow
Insider trades
What the people running Chemed Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $5.2M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 3, 2026 | Mcnamara Kevin Jpresident and CEO, Director | Sold | 2,000 | $1.1M |
| November 2, 2026 | Lee Spencer Sexecutive vice president | Sold | 920 | $494.2K |
| September 30, 2026 | Lee Spencer Sexecutive vice president | Exercised options | 12,099 | $5.4M |
| September 30, 2026 | Lee Spencer Sexecutive vice president | Shares withheld for tax | 11,160 | $5.7M |
| September 28, 2026 | Mcnamara Kevin Jpresident and CEO, Director | Sold | 2,000 | $1M |
| September 28, 2026 | Hutton Thomas Cvice president, Director | Exercised options | 4,629 | $2.1M |
| September 28, 2026 | Hutton Thomas Cvice president, Director | Shares withheld for tax | 4,270 | $2.2M |
| September 18, 2026 | Mcnamara Kevin Jpresident and CEO, Director | Sold | 2,000 | $1M |
Who owns CHE
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| AQR Capital Management, LLC13G, passive with 1 related filers | 7.25% | August 12, 2026 |
| Vanguard Portfolio Management13G, passive | 5.93% | April 29, 2026 |
| Vanguard Capital Management13G, passive | 5.4% | April 29, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 530 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 1,484,282 | +147,592 |
| Aqr Capital Management LLC | 972,474 | +556,862 |
| Vanguard Portfolio Management LLC | 787,068 | -28,631 |
| Vanguard Capital Management LLC | 604,420 | -31,650 |
| State Street Corp | 444,716 | -17,454 |
| Geode Capital Management, LLC | 413,942 | +2,896 |
| Jpmorgan Chase & Co | 403,395 | -97,592 |
| Boston Partners | 280,684 | new |
| Epoch Investment Partners, Inc. | 267,290 | +17,167 |
| Dimensional Fund Advisors LP | 260,561 | +12,711 |
| TD Asset Management Inc | 256,263 | -23,438 |
| River Road Asset Management, LLC | 237,927 | +166,159 |
| Morgan Stanley | 232,302 | +5,253 |
| Fuller & Thaler Asset Management, Inc. | 219,988 | +92,595 |
| First Trust Advisors LP | 219,788 | -16,604 |
| Boston Trust Walden Corp | 201,275 | -3,922 |
| Northern Trust Corp | 199,148 | +24,482 |
| Goldman Sachs Group Inc | 183,938 | +45,939 |
| Charles Schwab Investment Management Inc | 170,358 | +6,354 |
| Arrowstreet Capital, Limited Partnership | 166,149 | +13,680 |
Insiders
13 insiders reported holding 158,173 shares in total, about $85.3M at the last price.
| Holder | Shares |
|---|---|
| Mcnamara Kevin Jpresident and CEO, Director | 82,220 |
| Hutton Thomas Cvice president, Director | 32,840 |
| Lee Spencer Sexecutive vice president | 13,931 |
| Witzeman Michael DVP & Chief Financial Officer | 5,953 |
| Lindell Andrea RDirector | 4,578 |
| Grace Patrick PDirector | 3,533 |
| Judkins Brian CVP and Chief Legal Officer | 3,344 |
| Walsh George J IIIDirector | 3,209 |
| Heaney Christopher JDirector | 2,775 |
| DeLyons RonDirector | 2,052 |
Questions about CHE
What does Chemed Corp do?
Chemed Corp is a company in the Health care sector, listed on NYSE as CHE. Its shares trade on NYSE under the ticker CHE.
What is Chemed Corp's net worth?
Chemed Corp has a market value (market cap) of $7.1B at the latest share price, and shareholders' equity of $861.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Chemed Corp profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $282.4M on revenue of $2.7B, a net margin of 10.6%.
How much revenue does Chemed Corp make?
Over the twelve months to September 30, 2026 Chemed Corp reported revenue of $2.7B. That is 5.2% more than a year earlier.
When did Chemed Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade from November 5, 2026.
When is Chemed Corp's next earnings report?
Chemed Corp's next report is expected around February 24, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does Chemed Corp pay a dividend?
Yes. Chemed Corp paid dividends of $2.20 per share in fiscal 2025, a yield of 0.41% at the current price.
Similar companies
Compare CHE with
Follow CHE
Get an email when Chemed Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Chemed Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.